Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute

János Németh; Beáta Tapasztó; Wagih A Aclimandos; Philippe Kestelyn; Jost B Jonas; Jan-Tjeerd H N De Faber; Ingrida Januleviciene; Andrzej Grzybowski; Zoltán Zsolt Nagy; Olavi Pärssinen; Jeremy A Guggenheim; Peter M Allen; Rigmor C Baraas; Kathryn J Saunders; Daniel Ian Flitcroft; Lyle S Gray; Jan Roelof Polling; Annechien Eg Haarman; J Willem L Tideman; James Stuart Wolffsohn; Siegfried Wahl; Jeroen A Mulder; Irina Yurievna Smirnova; Marino Formenti; Hema Radhakrishnan; Serge Resnikoff

doi:10.1177/1120672121998960

Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute

János Németh, Beáta Tapasztó, Wagih A Aclimandos, Philippe Kestelyn, Jost B Jonas, Jan-Tjeerd H N De Faber, Ingrida Januleviciene, Andrzej Grzybowski, Zoltán Zsolt Nagy, Olavi Pärssinen, Jeremy A Guggenheim, Peter M Allen, Rigmor C Baraas, Kathryn J Saunders, Daniel Ian Flitcroft, Lyle S Gray, Jan Roelof Polling, Annechien Eg Haarman, J Willem L Tideman, James Stuart WolffsohnSiegfried Wahl, Jeroen A Mulder, Irina Yurievna Smirnova, Marino Formenti, Hema Radhakrishnan, Serge Resnikoff

Children's Eye Centre

Research output: Contribution to journal › Review article › peer-review

Abstract

The prevalence of myopia is increasing extensively worldwide. The number of people with myopia in 2020 is predicted to be 2.6 billion globally, which is expected to rise up to 4.9 billion by 2050, unless preventive actions and interventions are taken. The number of individuals with high myopia is also increasing substantially and pathological myopia is predicted to become the most common cause of irreversible vision impairment and blindness worldwide and also in Europe. These prevalence estimates indicate the importance of reducing the burden of myopia by means of myopia control interventions to prevent myopia onset and to slow down myopia progression. Due to the urgency of the situation, the European Society of Ophthalmology decided to publish this update of the current information and guidance on management of myopia. The pathogenesis and genetics of myopia are also summarized and epidemiology, risk factors, preventive and treatment options are discussed in details.

Original language	English
Pages (from-to)	853-883
Number of pages	31
Journal	European Journal of Ophthalmology
Volume	31
Issue number	3
Early online date	5 Mar 2021
DOIs	https://doi.org/10.1177/1120672121998960
Publication status	Published - May 2021

Access to Document

10.1177/1120672121998960

Cite this

Németh, J., Tapasztó, B., Aclimandos, W. A., Kestelyn, P., Jonas, J. B., De Faber, J.-T. H. N., Januleviciene, I., Grzybowski, A., Nagy, Z. Z., Pärssinen, O., Guggenheim, J. A., Allen, P. M., Baraas, R. C., Saunders, K. J., Flitcroft, D. I., Gray, L. S., Polling, J. R., Haarman, A. E., Tideman, J. W. L., ... Resnikoff, S. (2021). Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute. European Journal of Ophthalmology, 31(3), 853-883. https://doi.org/10.1177/1120672121998960

@article{8fc74bbc8a104eaca4bb46394ead8a58,

title = "Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute",

abstract = "The prevalence of myopia is increasing extensively worldwide. The number of people with myopia in 2020 is predicted to be 2.6 billion globally, which is expected to rise up to 4.9 billion by 2050, unless preventive actions and interventions are taken. The number of individuals with high myopia is also increasing substantially and pathological myopia is predicted to become the most common cause of irreversible vision impairment and blindness worldwide and also in Europe. These prevalence estimates indicate the importance of reducing the burden of myopia by means of myopia control interventions to prevent myopia onset and to slow down myopia progression. Due to the urgency of the situation, the European Society of Ophthalmology decided to publish this update of the current information and guidance on management of myopia. The pathogenesis and genetics of myopia are also summarized and epidemiology, risk factors, preventive and treatment options are discussed in details.",

keywords = "Myopia, atropine, blindness, myopia reduction interventions, orthokeratology, pathologic myopia, preventive medicine, time spent outdoors",

author = "J{\'a}nos N{\'e}meth and Be{\'a}ta Tapaszt{\'o} and Aclimandos, {Wagih A} and Philippe Kestelyn and Jonas, {Jost B} and {De Faber}, {Jan-Tjeerd H N} and Ingrida Januleviciene and Andrzej Grzybowski and Nagy, {Zolt{\'a}n Zsolt} and Olavi P{\"a}rssinen and Guggenheim, {Jeremy A} and Allen, {Peter M} and Baraas, {Rigmor C} and Saunders, {Kathryn J} and Flitcroft, {Daniel Ian} and Gray, {Lyle S} and Polling, {Jan Roelof} and Haarman, {Annechien Eg} and Tideman, {J Willem L} and Wolffsohn, {James Stuart} and Siegfried Wahl and Mulder, {Jeroen A} and Smirnova, {Irina Yurievna} and Marino Formenti and Hema Radhakrishnan and Serge Resnikoff",

year = "2021",

month = may,

doi = "10.1177/1120672121998960",

language = "English",

volume = "31",

pages = "853--883",

number = "3",

}

Németh, J, Tapasztó, B, Aclimandos, WA, Kestelyn, P, Jonas, JB, De Faber, J-THN, Januleviciene, I, Grzybowski, A, Nagy, ZZ, Pärssinen, O, Guggenheim, JA, Allen, PM, Baraas, RC, Saunders, KJ, Flitcroft, DI, Gray, LS, Polling, JR, Haarman, AE, Tideman, JWL, Wolffsohn, JS, Wahl, S, Mulder, JA, Smirnova, IY, Formenti, M, Radhakrishnan, H & Resnikoff, S 2021, 'Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute', European Journal of Ophthalmology, vol. 31, no. 3, pp. 853-883. https://doi.org/10.1177/1120672121998960

TY - JOUR

T1 - Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute

AU - Németh, János

AU - Tapasztó, Beáta

AU - Aclimandos, Wagih A

AU - Kestelyn, Philippe

AU - Jonas, Jost B

AU - De Faber, Jan-Tjeerd H N

AU - Januleviciene, Ingrida

AU - Grzybowski, Andrzej

AU - Nagy, Zoltán Zsolt

AU - Pärssinen, Olavi

AU - Guggenheim, Jeremy A

AU - Allen, Peter M

AU - Baraas, Rigmor C

AU - Saunders, Kathryn J

AU - Flitcroft, Daniel Ian

AU - Gray, Lyle S

AU - Polling, Jan Roelof

AU - Haarman, Annechien Eg

AU - Tideman, J Willem L

AU - Wolffsohn, James Stuart

AU - Wahl, Siegfried

AU - Mulder, Jeroen A

AU - Smirnova, Irina Yurievna

AU - Formenti, Marino

AU - Radhakrishnan, Hema

AU - Resnikoff, Serge

PY - 2021/5

Y1 - 2021/5

N2 - The prevalence of myopia is increasing extensively worldwide. The number of people with myopia in 2020 is predicted to be 2.6 billion globally, which is expected to rise up to 4.9 billion by 2050, unless preventive actions and interventions are taken. The number of individuals with high myopia is also increasing substantially and pathological myopia is predicted to become the most common cause of irreversible vision impairment and blindness worldwide and also in Europe. These prevalence estimates indicate the importance of reducing the burden of myopia by means of myopia control interventions to prevent myopia onset and to slow down myopia progression. Due to the urgency of the situation, the European Society of Ophthalmology decided to publish this update of the current information and guidance on management of myopia. The pathogenesis and genetics of myopia are also summarized and epidemiology, risk factors, preventive and treatment options are discussed in details.

AB - The prevalence of myopia is increasing extensively worldwide. The number of people with myopia in 2020 is predicted to be 2.6 billion globally, which is expected to rise up to 4.9 billion by 2050, unless preventive actions and interventions are taken. The number of individuals with high myopia is also increasing substantially and pathological myopia is predicted to become the most common cause of irreversible vision impairment and blindness worldwide and also in Europe. These prevalence estimates indicate the importance of reducing the burden of myopia by means of myopia control interventions to prevent myopia onset and to slow down myopia progression. Due to the urgency of the situation, the European Society of Ophthalmology decided to publish this update of the current information and guidance on management of myopia. The pathogenesis and genetics of myopia are also summarized and epidemiology, risk factors, preventive and treatment options are discussed in details.

KW - Myopia

KW - atropine

KW - blindness

KW - myopia reduction interventions

KW - orthokeratology

KW - pathologic myopia

KW - preventive medicine

KW - time spent outdoors

UR - https://www.mendeley.com/catalogue/5692bdd4-a85b-3c37-be10-c3524e2d60ab/

U2 - 10.1177/1120672121998960

DO - 10.1177/1120672121998960

M3 - Review article

C2 - 33673740

SN - 1120-6721

VL - 31

SP - 853

EP - 883

JO - European Journal of Ophthalmology

JF - European Journal of Ophthalmology

IS - 3

ER -

Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute

Abstract

Access to Document

Other files and links

Fingerprint

Cite this